Docetaxel and Mitoxantrone Prior to Radical Prostatectomy in Men with High Risk Prostate Cancer: Ten-Year Follow Up and Immune Correlates

OBJECTIVES. To report the clinical outcomes a cohort of men with high-risk prostate cancer treated with neoadjuvant docetaxel and mitoxantrone ten years after treatment. To identify pretreatment clinical parameters that maybe predictors of recurrence, and to describe tumor infiltrating leukocytes pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Anticancer Drugs
Autores principales: Bergstrom, Colin P., Ruffell, Brian, Ho, Christine M.T., Higano, Celestia S., Ellis, William J., Garzotto, Mark, Beer, Tomasz M., Graff, Julie N.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370800/
https://ncbi.nlm.nih.gov/pubmed/27669423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000438
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares